9241074

Source:http://linkedlifedata.com/resource/pubmed/id/9241074

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021083, umls-concept:C0021745, umls-concept:C0150369, umls-concept:C0439859, umls-concept:C0920321, umls-concept:C1155229, umls-concept:C1513095, umls-concept:C1517476
pubmed:issue	3
pubmed:dateCreated	1997-8-12
pubmed:abstractText	Tumor cells transduced with cytokine genes provide immunogenic vaccines for cancer immunotherapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1R01-CA-64959-01
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9241074
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0008-543X
pubmed:author	pubmed-author:Abdel-WahabZZ, pubmed-author:BarberJ RJR, pubmed-author:HesterDD, pubmed-author:JollyDD, pubmed-author:PickettNN, pubmed-author:SeiglerH FHF, pubmed-author:VervaertCC, pubmed-author:WeltyDD
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	80
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	401-12
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:9241074-Cancer Vaccines, pubmed-meshheading:9241074-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9241074-Female, pubmed-meshheading:9241074-Gene Therapy, pubmed-meshheading:9241074-Gene Transfer Techniques, pubmed-meshheading:9241074-Histocompatibility Antigens Class I, pubmed-meshheading:9241074-Histocompatibility Antigens Class II, pubmed-meshheading:9241074-Humans, pubmed-meshheading:9241074-Immunoglobulin G, pubmed-meshheading:9241074-Immunotherapy, Active, pubmed-meshheading:9241074-Interferon-gamma, pubmed-meshheading:9241074-Major Histocompatibility Complex, pubmed-meshheading:9241074-Male, pubmed-meshheading:9241074-Melanoma, pubmed-meshheading:9241074-Middle Aged, pubmed-meshheading:9241074-Radioimmunoassay, pubmed-meshheading:9241074-Radioimmunoprecipitation Assay, pubmed-meshheading:9241074-Remission Induction
pubmed:year	1997
pubmed:articleTitle	A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response.
pubmed:affiliation	Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Clinical Trial, Phase I